CDTX: Cidara Therapeutics, Inc. Stock

by  •  • Comments Off on CDTX: Cidara Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 348.89
Enterprise Value ($M) 180.74
Book Value ($M) 141.68
Book Value / Share 10.92
Price / Book 2.46
NCAV ($M) 138.80
NCAV / Share 10.70
Price / NCAV 2.51

Profitability (mra)
Return on Invested Capital (ROIC) -1.27
Return on Assets (ROA) -3.47
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 3.87
Current Ratio 3.87

Balance Sheet (mrq) ($M)
Current Assets 188.85
Assets 191.73
Liabilities 50.05
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1.27
Operating Income -91.22
Net Income -169.83
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -176.53
Cash from Investing -0.13
Cash from Financing 337.06

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
6 days ago 13G/A Venrock Healthcare Capital Partners III, L.P. 9.90 -63.02
6 days ago 13G/A Vivo Opportunity Fund Holdings, L.P. 4.70 2.02
6 days ago 13G/A Biotechnology Value Fund L P 9.99 14.54
9 days ago 13G Adage Capital Management, L.P. 9.04
04-16 13G Point72 Asset Management, L.P. 9.10 -20.06
12-03 13G TCG Crossover GP II, LLC 9.20
11-26 13D/A Ra Capital Management, L.p. 9.99 55.43
07-29 13G Canaan XII L.P. 9.99
07-29 13G BCLS Fund III Investments, LP 9.99

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2025-03-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-20 28,398 279,235 10.17
2025-05-19 72,538 374,454 19.37
2025-05-16 56,908 268,939 21.16
2025-05-15 36,743 269,594 13.63

(click for more detail)

Similar Companies
CAPR – Capricor Therapeutics, Inc. CASI – CASI Pharmaceuticals, Inc.
CDIO – Cardio Diagnostics Holdings, Inc. CELU – Celularity Inc.
CELZ – Creative Medical Technology Holdings, Inc.


Financial data and stock pages provided by
Fintel.io